Phase 4 N=292 Prevention

Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home

Influenza

Bottom Line

View on ClinicalTrials.gov: NCT00812110 ↗

Enrolled (actual)

292

Serious AEs

0.0%

Results posted

Jan 2013

Primary outcome: Primary: Number of Participants Who Received Influenza Vaccine. — 250 participants

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: Influenzae vaccine (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Akron Children's Hospital
Primary completion: Sep 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants Who Received Influenza Vaccine.	250	—
SECONDARY Background Rate of Influenza Vaccination in the Parents/Caregivers of High Risk Pediatric Patients in a Low Income Population?	69	—

Summary

We hypothesize that when offered influenza vaccine at little or no cost, in a setting where the value of the vaccine is connected to one's high risk child, vaccination rates for parents will approach 90-95%, similar to rates obtained in the Neonatal Intensive Care Unit environment.

Eligibility Criteria

Inclusion Criteria

Parents or caregiver adults who accompany at-risk children to a Pediatric Care outpatient clinic appointment. High risk children are defined as those 0 to 5 years of age, or who have any of the following diagnoses:
Sickle cell disease
Asthma
Cystic fibrosis
Chronic renal disease
Congenital heart disease
Cancer
Any immunodeficiency

Exclusion Criteria

Caregivers of children residing in group homes
Persons whose children do not meet the Center for Disease Control (CDC) definition of high-risk
Persons who have had allergic reactions to influenza vaccination or any other vaccination in the past
Persons who are allergic to eggs or egg products
Persons who are allergic to thimerosol
Previous diagnosis of Guillain-Barré syndrome (GBS)
Persons who are moderately to severely ill at the time the vaccination is to be given

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00812110). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.